KEGG pathway | KEGG category | n. | P |
---|---|---|---|
Cytokine-cytokine receptor interaction | Â | 14 | 9.69e-26 |
Cell adhesion molecules (CAMs) | Signaling Molecules and Interaction | 1 | 7.59e-2 |
Neuroactive ligand-receptor interaction | Â | 1 | 1.67e-1 |
Hematopoietic cell lineage | Â | 7 | 6.00e-14 |
Natural killer cell mediated cytotoxicity | Â | 4 | 9.12e-7 |
Toll-like receptor signaling pathway | Immune System | 3 | 2.19e-5 |
Fc epsilon RI signaling pathway | Â | 2 | 1.01e-3 |
Leukocyte transendothelial migration | Â | 2 | 2.29e-3 |
T cell receptor signaling pathway | Â | 1 | 5.57e-2 |
Apoptosis | Cell Growth and Death | 5 | 1.54e-9 |
MAPK signaling pathway | Â | 4 | 2.21e-5 |
Jak-STAT signaling pathway | Signal Transduction | 4 | 1.90e-6 |
TGF-beta signaling pathway | Â | 1 | 4.96e-2 |
Adipocytokine signaling pathway | Endocrine System | 3 | 1.13e-5 |
PPAR signaling pathway | Â | 1 | 4.17e-2 |
Epithelial cell signaling in Helicobacter pylori infection | Infectious Diseases | 2 | 8.05e-4 |
Gap junction | Cell Communication | 2 | 1.33e-3 |
Focal adhesion | Â | 2 | 6.43e-3 |
Glioma | Cancers | 2 | 6.66e-4 |
Pancreatic cancer | Â | 1 | 4.42e-2 |
Type I diabetes mellitus | Metabolic Diseases | 2 | 2.96e-4 |
Type II diabetes mellitus | Â | 2 | 3.26e-4 |
Regulation of actin cytoskeleton | Cell Motility | 2 | 6.89e-3 |